Aridis Pharmaceuticals Dividends and Buybacks
Dividend criteria checks 0/6
Aridis Pharmaceuticals does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-30,954,717.0%
Buyback Yield
| Total Shareholder Yield | -30,954,717.0% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Aridis Pharmaceuticals announces proposed public stock offering; shares down ~30%
Sep 26Aridis Pharmaceuticals GAAP EPS of -$0.45, revenue of $0.29M
Aug 16Can You Imagine How Aridis Pharmaceuticals' (NASDAQ:ARDS) Shareholders Feel About The 32% Share Price Increase?
Feb 17
Aridis Pharmaceuticals EPS misses by $0.02
Nov 20Aridis Pharmaceuticals (ARDS) Investor Presentation - Slideshow
Oct 31Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if ARDS's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ARDS's dividend payments have been increasing.
Dividend Yield vs Market
| Aridis Pharmaceuticals Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (ARDS) | n/a |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.2% |
| Industry Average (Biotechs) | 2.3% |
| Analyst forecast (ARDS) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate ARDS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ARDS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate ARDS's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as ARDS has not reported any payouts.